Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Schedule of Outstanding Shares of Common Stock Equivalents Excluded from Calculation (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 37,755,000 23,490,000 37,755,000 23,490,000
Common shares underlying convertible debt        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 5,661,025 5,303,591 5,661,025 5,303,591
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 136,187,225 133,945,796 136,187,225 134,917,225
Unvested restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 4,000,000 0 4,000,000 0